Our Blog | Biosimilars & Generics | AAM

New Blog - Jonathan Kimball gives more detail re: AAM's blueprint & proposed policy framework

Carole Ben-Maimon—President and CEO of Larimar Therapeutics

Jul 30, 2020 | Bob Billings

Thank you, Carole Ben-Maimon

GRx+Biosims: Generics + Biosimilars Virtual Conference

Jul 29, 2020 | Jennifer Soup

GRx+Biosims 2020: Join Us Virtually November 9-11 

Sick boy with thermometer laying in bed and mother hand taking temperature. Mother checking temperature of her sick son who has thermometer in his mouth.

Jul 1, 2020 | Erik Komendant

Why—and How—the U.S. Should Develop a List of Essential Medicines

Photo collage of diverse people taking selfies

Jun 29, 2020 | Erica Klinger

America’s Patients: Share Your Story

Lupin Pharmaceutical and Chairman Desh Bandhu Gupta

Jun 26, 2020 | Bob Billings

Thank you, Desh Bandhu Gupta

Cropped shot of a pharmacist filling a prescription at a chemist

Jun 17, 2020 | Katherine Raab

How “Stocking the Pantry” Protects the Supply Chain

The New York Times article: Agnes Varis, Founder of Drug Company, Dies at 81

Jun 16, 2020 | Bob Billings

Thank you, Agnes Varis

Side view of the capsule in production line.

Jun 4, 2020 | Jonathan Kimball

Strengthening the U.S. Pharmaceutical Supply Chain: What We Know—and What We Don’t

Elderly patient - medicare and low cost generic medicines

May 13, 2020 | Craig Burton

AAM Supports Updating Medicare to Lower Costs for America’s Seniors

Preview of The New York Times article: William Haddad, Crusader for Generic Drugs, Dies at 91

May 13, 2020 | Bob Billings

Thank You, Bill Haddad

AAM Blueprint for U.S. Pharmaceutical Supply Chain - header

Apr 30, 2020 | Jonathan Kimball

AAM’s Plan for Strengthening the Generic Drug Supply Chain

Protective Mask - COVID-19

Mar 30, 2020 | Jeff Francer

COVID-19: This Week’s Initiatives From the Generic and Biosimilars Industry